We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$947M
AUM Growth
+$42.3M
Cap. Flow
-$10.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
37.5%
Holding
265
New
13
Increased
83
Reduced
137
Closed
13

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.48M
2
DHI icon
D.R. Horton
DHI
+$4.76M
3
CSCO icon
Cisco
CSCO
+$4.46M
4
STZ icon
Constellation Brands
STZ
+$4.2M
5
DGX icon
Quest Diagnostics
DGX
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 21.18%
2 Healthcare 10.11%
3 Financials 8.69%
4 Consumer Discretionary 6.97%
5 Industrials 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
126
Starbucks
SBUX
$118B
$1.27M 0.13%
12,838
-1,661
-11% -$172K
RMD icon
127
ResMed
RMD
$29.5B
$1.27M 0.13%
+5,801
New +$1.29M
ZBH icon
128
Zimmer Biomet
ZBH
$17.8B
$1.26M 0.13%
8,658
LNTH icon
129
Lantheus
LNTH
$7.03B
$1.25M 0.13%
+14,947
New +$1.34M
CINF icon
130
Cincinnati Financial
CINF
$28.5B
$1.23M 0.13%
12,588
SLYV icon
131
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.9B
$1.19M 0.13%
15,456
+1,329
+9% +$98.8K
BAC icon
132
Bank of America
BAC
$436B
$1.14M 0.12%
39,757
-11,820
-23% -$337K
GLW icon
133
Corning
GLW
$123B
$1.12M 0.12%
31,917
+1,635
+5% +$53.7K
CVX icon
134
Chevron
CVX
$378B
$1.1M 0.12%
6,985
+406
+6% +$65.1K
GPC icon
135
Genuine Parts
GPC
$17.6B
$1.08M 0.11%
6,371
+5,079
+393% +$831K
ETR icon
136
Entergy
ETR
$53.1B
$1.08M 0.11%
22,120
-492
-2% -$25.5K
DGX icon
137
Quest Diagnostics
DGX
$25.6B
$1.06M 0.11%
7,516
-13,034
-63% -$1.8M
SYK icon
138
Stryker
SYK
$129B
$1.05M 0.11%
3,432
-620
-15% -$179K
BRK.A icon
139
Berkshire Hathaway Class A
BRK.A
$1.07T
$1.04M 0.11%
2
AVGO icon
140
Broadcom
AVGO
$1.82T
$1M 0.11%
11,540
LLY icon
141
Eli Lilly
LLY
$1.07T
$950K 0.1%
2,026
-170
-8% -$71.3K
SPEM icon
142
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.1B
$913K 0.1%
26,542
-19,548
-42% -$668K
TJX icon
143
TJX Companies
TJX
$173B
$875K 0.09%
10,317
-3,612
-26% -$285K
SLYG icon
144
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.07B
$866K 0.09%
11,253
+255
+2% +$18.6K
EFG icon
145
iShares MSCI EAFE Growth ETF
EFG
$16.4B
$855K 0.09%
8,956
-1,653
-16% -$157K
MDYG icon
146
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.85B
$848K 0.09%
11,830
-1,076
-8% -$73.5K
PM icon
147
Philip Morris
PM
$305B
$842K 0.09%
8,624
+276
+3% +$26.4K
BA icon
148
Boeing
BA
$167B
$804K 0.08%
3,806
-106
-3% -$22K
ETN icon
149
Eaton
ETN
$155B
$782K 0.08%
3,890
+144
+4% +$25.3K
XLC icon
150
State Street Communication Services Select Sector SPDR ETF
XLC
$22.1B
$756K 0.08%
11,609
-18,371
-61% -$1.12M

Similar funds

Girard Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Girard Partners held 265 positions worth $947M, up 4.7% from $904M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Girard Partners's Q2 2023 filing shows 13 new, 83 increased, 137 reduced and 13 closed positions. Its largest new stake was Charles River Laboratories: 20,680 shares worth $4.35M. The largest sale was Amgen, an estimated $5.48M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Girard Partners's largest Q2 2023 buy was Charles River Laboratories: 20,680 shares worth $4.35M.
  • Girard Partners added most to Estee Lauder in Q2 2023, an estimated $3.62M increase.
  • Girard Partners's biggest Q2 2023 reduction was Amgen, cutting an estimated $5.48M.
  • Girard Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2023, selling an estimated $608K.
  • Girard Partners's ten largest holdings make up 37% of its $947M portfolio in Q2 2023.
  • Girard Partners opened 13 new positions and closed 13 in Q2 2023.
  • Girard Partners's portfolio value rose 4.7% quarter-over-quarter to $947M.

Based on Girard Partners's 13F filing for Q2 2023, filed 15 Aug 2023.